...
首页> 外文期刊>Haemophilia: the official journal of the World Federation of Hemophilia >Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families--15 new mutations.
【24h】

Molecular diagnosis of haemophilia A at Centro Hospitalar de Coimbra in Portugal: study of 103 families--15 new mutations.

机译:葡萄牙科英布拉中心医院的A型血友病分子诊断:103个家族的研究--15个新突变。

获取原文
获取原文并翻译 | 示例
           

摘要

Haemophilia A (HA), the most commonly inherited bleeding disorder, has well known phenotype heterogeneity, influenced by the type of mutation, modulating factors and development of inhibitors. Nowadays, new technologies in association with bioinformatics tools allow a better genotype/phenotype correlation. With the main objective of identifying familial carrier women and to offer prenatal diagnosis, 141 HA patients belonging to 103 families, followed or referred to the Haemophilia Centre of CHC, E.P.E., were studied. Molecular diagnosis strategy was based on HA severity: IVS22 and IVS1 inversions, direct sequencing and MLPA technique. New missense and splicing mutations were further analyzed using molecular modelling. Genotype/phenotype correlation was assessed taking into account the known modulating factors. During this study, mutations were detected in 102/103 families, carrier status was determined in 83 women and 14 prenatal diagnoses were performed. In a total of 46 different mutations identified, 15 have not been reported previously by the HAMSTeRS and HGMD. Genotype/phenotype correlation revealed two cases with a clinical picture less severe than expected by the type of mutation identified. Six patients developed inhibitors: five severe (IVS22, IVS1, large deletion) and one mild (p. Gln2265Lys). The adopted strategy allowed the identification of 99% of the molecular alterations underlying the HA phenotype (98% detection rate for severe and 100% for moderate and mild). Evaluation of genotype-phenotype correlation was complemented with structural protein modelling of newly identified missense mutations, contributing to better understanding of the disease-causing mechanisms and to deepening knowledge on protein structure-function.
机译:血友病A(HA)是最常见的遗传性出血病,具有众所周知的表型异质性,受突变类型,调节因子和抑制剂发展的影响。如今,与生物信息学工具相关的新技术可以实现更好的基因型/表型相关性。为了确定家族携带者妇女并提供产前诊断的主要目的,研究了141个属于103个家庭的HA患者,随后对其进行了追踪或将其转介给CHC E.P.E.的血友病中心。分子诊断策略基于HA严重程度:IVS22和IVS1倒置,直接测序和MLPA技术。使用分子建模进一步分析了新的错义和剪接突变。考虑到已知的调节因子,评估基因型/表型的相关性。在这项研究中,在102/103个家庭中检测到突变,在83名妇女中确定了携带者的状态,并进行了14次产前诊断。在总共鉴定出的46种不同突变中,HAMSTeRS和HGMD先前未报告过15种。基因型/表型的相关性揭示了两个病例,其临床表现不如所鉴定的突变类型预期的严重。 6名患者出现了抑制物:5种是重度抑制剂(IVS22,IVS1,大缺失)和一种是轻度抑制剂(第Gln2265Lys)。所采用的策略可以识别出HA表型的99%分子改变(重度检出率为98%,中度和轻度检出率为100%)。基因型-表型相关性的评估与新发现的错义突变的结构蛋白建模相辅相成,有助于更好地了解引起疾病的机制并加深对蛋白结构功能的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号